Skip to main navigation Skip to search Skip to main content

The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates

  • A. Harrison
  • , C. A. Walker
  • , D. Parker
  • , K. J. Jankowski
  • , J. P.L. Cox
  • , A. S. Craig
  • , J. M. Sansom
  • , N. R.A. Beeley
  • , R. A. Boyce
  • , L. Chaplin
  • , M. A.W. Eaton
  • , A. P.H. Farnsworth
  • , K. Millar
  • , A. T. Millican
  • , A. M. Randall
  • , S. K. Rhind
  • , D. S. Secher
  • , A. Turner

Research output: Contribution to journal › Journal article › peer-review

86 Citations (Scopus)

Abstract

Yttrium binding ligands DOTA, caDTPA and CT-DTPA were each conjugated to monoclonal antibody B72.3, labelled with 90Y and injected into mice in order to assess the in vivo inertness of the antibody-linked 90Y-ligand complexes. Levels of 90Y in femur shafts of the DOTA-B72.3 mice were low, being ~ 7 and 44%, respectively, of levels in the femur shafts of the caDTPA-B72.3 and CT-DTPA-B72.3 treated mice. This finding demonstrates the greater inertness and by implication the greater suitability for immunotherapy of the DOTA-90Y complex.

Original languageEnglish
Pages (from-to)469-476
Number of pages8
JournalInternational Journal of Radiation Applications and Instrumentation
Volume18
Issue number5
DOIs
Publication statusPublished - Jul 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 9 - Industry, Innovation, and Infrastructure
    SDG 9 Industry, Innovation, and Infrastructure

Fingerprint

Dive into the research topics of 'The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates'. Together they form a unique fingerprint.

Cite this